|Bid||10.96 x 1000|
|Ask||11.10 x 1000|
|Day's Range||10.93 - 11.11|
|52 Week Range||10.75 - 18.43|
|Beta (5Y Monthly)||1.96|
|PE Ratio (TTM)||3.43|
|Earnings Date||Mar 02, 2022 - Mar 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Mar 30, 2020|
|1y Target Est||19.50|
SAN CLEMENTE, Calif., May 04, 2022--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financial results for the first quarter ended March 31, 2022. Key highlights include:
ACRES Commercial Realty Corp. (NYSE:ACR) (the "Company") announced today that it will release its first quarter 2022 results on Thursday, May 5, 2022, after the market closes. The Company invites investors and other interested parties to listen to its live conference call via telephone or webcast on Thursday, May 5, 2022, at 5:00 p.m. Eastern Time.
ACRES Commercial Realty Corp. ( NYSE:ACR ) shareholders should be happy to see the share price up 20% in the last...